Steffen Bauer

6.6k total citations · 2 hit papers
85 papers, 5.0k citations indexed

About

Steffen Bauer is a scholar working on Pharmacology, Transplantation and Molecular Biology. According to data from OpenAlex, Steffen Bauer has authored 85 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 16 papers in Transplantation and 15 papers in Molecular Biology. Recurrent topics in Steffen Bauer's work include Pharmacogenetics and Drug Metabolism (19 papers), Renal Transplantation Outcomes and Treatments (16 papers) and Pharmacological Effects and Toxicity Studies (13 papers). Steffen Bauer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Renal Transplantation Outcomes and Treatments (16 papers) and Pharmacological Effects and Toxicity Studies (13 papers). Steffen Bauer collaborates with scholars based in Germany, United States and Austria. Steffen Bauer's co-authors include Ivar Roots, Jürgen Brockmöller, Christoph Sachse, Julia Kirchheiner, Klemens Budde, Ingrid Mai, Elke Störmer, Ingolf Meineke, Andreas Johne and Christian Meisel and has published in prestigious journals such as Journal of Clinical Oncology, Small and Journal of Neurochemistry.

In The Last Decade

Steffen Bauer

82 papers receiving 4.8k citations

Hit Papers

Cytochrome P450 2D6 variants in a Caucasian population: a... 1997 2026 2006 2016 1997 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffen Bauer Germany 37 2.1k 1.2k 911 900 762 85 5.0k
Laurent Becquemont France 39 1.8k 0.8× 1.3k 1.1× 1.0k 1.1× 791 0.9× 958 1.3× 171 5.9k
Céline Verstuyft France 36 1.2k 0.6× 1.0k 0.9× 1.0k 1.1× 487 0.5× 806 1.1× 131 4.8k
Yasufumi Sawada Japan 46 2.1k 1.0× 2.9k 2.5× 1.7k 1.8× 1.8k 2.0× 965 1.3× 362 7.7k
Hisakazu Ohtani Japan 35 946 0.4× 1.6k 1.3× 974 1.1× 1.0k 1.1× 567 0.7× 176 4.2k
Reginald F. Frye United States 40 1.8k 0.8× 924 0.8× 576 0.6× 1.0k 1.1× 924 1.2× 160 5.2k
Lisa L. von Moltke United States 62 5.0k 2.3× 2.9k 2.4× 1.9k 2.1× 1.5k 1.7× 1.5k 2.0× 147 9.2k
Hong‐Hao Zhou China 49 1.7k 0.8× 1.4k 1.2× 557 0.6× 3.6k 4.0× 833 1.1× 258 7.8k
Joo‐Youn Cho South Korea 40 1.1k 0.5× 1.3k 1.1× 741 0.8× 1.6k 1.8× 494 0.6× 289 5.8k
Jules Desmeules Switzerland 42 1.9k 0.9× 802 0.7× 956 1.0× 774 0.9× 1.3k 1.7× 240 6.4k
Roger K. Verbeeck Belgium 36 1.4k 0.6× 817 0.7× 807 0.9× 647 0.7× 1.2k 1.6× 156 4.7k

Countries citing papers authored by Steffen Bauer

Since Specialization
Citations

This map shows the geographic impact of Steffen Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Bauer more than expected).

Fields of papers citing papers by Steffen Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Bauer. The network helps show where Steffen Bauer may publish in the future.

Co-authorship network of co-authors of Steffen Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Bauer. A scholar is included among the top collaborators of Steffen Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Bauer. Steffen Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wehland, Markus, Steffen Bauer, Susanne Brakemeier, et al.. (2010). Differential impact of the CYP3A5*1 and CYP3A5*3 alleles on pre-dose concentrations of two tacrolimus formulations. Pharmacogenetics and Genomics. 21(4). 179–184. 41 indexed citations
2.
Fotopoulou, Christina, Rebekka Kretz, Steffen Bauer, et al.. (2009). Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Research. 85(1). 60–64. 73 indexed citations
3.
Brockmöller, Jürgen, et al.. (2009). Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 86(1). 54–61. 41 indexed citations
4.
Bauer, Steffen, et al.. (2008). St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive. European Journal of Clinical Pharmacology. 65(3). 287–294. 29 indexed citations
5.
Seeringer, Angela, Jürgen Brockmöller, Steffen Bauer, & Julia Kirchheiner. (2008). Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate. European Journal of Clinical Pharmacology. 64(9). 883–888. 13 indexed citations
6.
Budde, Klemens, Steffen Bauer, Pia Hambach, et al.. (2007). Pharmacokinetic and Pharmacodynamic Comparison of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients. American Journal of Transplantation. 7(4). 888–898. 93 indexed citations
7.
Bauer, Steffen. (2006). Does Bureaucracy Really Matter? The Authority of Intergovernmental Treaty Secretariats in Global Environmental Politics. Global Environmental Politics. 6(1). 23–49. 4 indexed citations
8.
9.
Arold, Gerhard, Frank Donath, Konstanze Diefenbach, et al.. (2005). No Relevant Interaction with Alprazolam, Caffeine, Tolbutamide, and Digoxin by Treatment with a Low-Hyperforin St John’s Wort Extract. Planta Medica. 71(4). 331–337. 70 indexed citations
10.
Kirchheiner, Julia, Steffen Bauer, Christian Meisel, et al.. (2004). Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics. Clinical Pharmacology & Therapeutics. 76(4). 302–312. 94 indexed citations
11.
Mai, Ingrid, Steffen Bauer, Elke S. Perloff, et al.. (2004). Hyperforin content determines the magnitude of the St John's wort–cyclosporine drug interaction. Clinical Pharmacology & Therapeutics. 76(4). 330–340. 102 indexed citations
12.
Mai, Ingrid, Elke Störmer, Steffen Bauer, et al.. (2003). Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrology Dialysis Transplantation. 18(4). 819–822. 110 indexed citations
13.
Glander, Petra, Pia Hambach, Steffen Bauer, et al.. (2001). Non-radioactive determination of inosine 5′-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells. Clinical Biochemistry. 34(7). 543–549. 72 indexed citations
14.
Bauer, Steffen, Elke Störmer, Hans‐Joachim Graubaum, & Ivar Roots. (2001). Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 765(1). 29–35. 36 indexed citations
15.
Budde, Klemens, Petra Glander, Steffen Bauer, et al.. (2000). Pharmacodynamic Monitoring of Mycophenolate Mofetil. Clinical Chemistry and Laboratory Medicine (CCLM). 38(11). 1213–6. 56 indexed citations
16.
Mai, Ingrid, Lutz Fritsche, G. Rohde, et al.. (1999). Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clinical Pharmacology & Therapeutics. 65(3). 251–261. 113 indexed citations
17.
Bauer, Steffen, et al.. (1998). Quantification of the antipsychotics flupentixol and haloperidol in human serum by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 720(1-2). 231–237. 35 indexed citations
18.
Donath, Frank, et al.. (1996). Oral bioavailability of bromelain and trypsin after repeated oral administration of a commercial polyenzyme preparation. European Journal of Clinical Pharmacology. 50(6). 548. 2 indexed citations
19.
Sachse, Christoph, Jürgen Brockmöller, Steffen Bauer, Torsten Reum, & Ivar Roots. (1996). A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15. Pharmacogenetics. 6(3). 269–272. 16 indexed citations
20.
Bauer, Steffen, J. Brockmöller, H. Kewitz, & Ivar Roots. (1992). The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.. PubMed. 30(11). 540–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026